PUMAPATIENTLYNX
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Mar 2019)
What this means for you
This application is over — abandoned 11 Mar 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87522915
- Mark type
- Design + words
- Filed
- 11 Jul 2017
- Published for opposition
- 12 Dec 2017
- Abandoned
- 11 Mar 2019
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the prevention and treatment of cancer
Owner
- Puma Biotechnology Inc., Los Angeles, CA, US
- Puma Biotechnology Inc., Los Angeles, CA, US
Prosecution history
- 11 Mar 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Mar 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2018 — SOU EXTENSION 1 GRANTED
- 13 Jun 2018 — SOU EXTENSION 1 FILED
- 13 Jun 2018 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Dec 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Dec 2017 — PUBLISHED FOR OPPOSITION
- 22 Nov 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2017 — ASSIGNED TO LIE
- 22 Oct 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Oct 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Oct 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Oct 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED